CC BY 4.0 · Indian Journal of Neurotrauma
DOI: 10.1055/s-0045-1807265
Review Article

Role of the Gut-Brain Axis in Severe Traumatic Brain Injury: Insights from Experimental Models and Clinical Studies

Venencia Albert
1   Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Center, All India Institute of Medical Sciences, New Delhi, India
,
1   Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Center, All India Institute of Medical Sciences, New Delhi, India
,
2   Department of Neurosurgery & Gamma-Knife, All India Institute of Medical Sciences, New Delhi, India
› Institutsangaben

Abstract

Introduction Traumatic brain injury (TBI) induces systemic alterations, including gut microbiome dysbiosis, increased intestinal permeability, and neuroinflammatory responses. This review explores the bidirectional gut-brain interactions, focusing on microbiome alterations, systemic inflammation, and potential therapeutic interventions.

Materials and Methods A comprehensive review of preclinical and human studies was conducted to assess gut microbiota changes following TBI. Key findings on microbial shifts, gut permeability, neuroinflammatory markers, and therapeutic strategies were analyzed.

Results Experimental animal models demonstrate that TBI leads to gut microbiota dysbiosis, loss of short-chain fatty acid-producing bacteria, and increased bacterial translocation due to impaired intestinal barrier function. These alterations exacerbate neuroinflammatory cascades, including microglial activation, cytokine release, and oxidative stress. Dysbiosis-induced metabolic shifts influence tryptophan metabolism and kynurenine pathway activation, contributing to excitotoxicity and neurodegeneration. Human studies reveal persistent microbiota imbalances in severe TBI patients, correlating with systemic inflammation and prolonged recovery.

Conclusion Despite growing evidence linking gut microbiome alterations to neuroinflammation and secondary brain injury, challenges remain in translating preclinical findings to clinical applications. Heterogeneity in experimental models, variability in microbiome assessment techniques, and gaps in mechanistic understanding hinder standardization. Emerging microbiome-targeted therapies, including probiotics, offer promising avenues for modulating systemic inflammation and improving neurological recovery post-TBI. Further research is needed to establish causal relationships, optimize therapeutic strategies, and evaluate long-term outcomes.



Publikationsverlauf

Artikel online veröffentlicht:
04. April 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 2015; 28 (02) 203-209
  • 2 Tiwari P, Dwivedi R, Bansal M, Tripathi M, Dada R. Role of gut microbiota in neurological disorders and its therapeutic significance. J Clin Med 2023; 12 (04) 1650
  • 3 Loh JS, Mak WQ, Tan LKS. et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 2024; 9 (01) 37
  • 4 Morais LH, Schreiber IV HL, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol 2021; 19 (04) 241-255
  • 5 Burmeister DM, Johnson TR, Lai Z. et al. The gut microbiome distinguishes mortality in trauma patients upon admission to the emergency department. J Trauma Acute Care Surg 2020; 88 (05) 579-587
  • 6 Montagnani M, Bottalico L, Potenza MA. et al. The crosstalk between gut microbiota and nervous system: a bidirectional interaction between microorganisms and metabolome. Int J Mol Sci 2023; 24 (12) 10322
  • 7 Urban RJ, Pyles RB, Stewart CJ. et al. Altered fecal microbiome years after traumatic brain injury. J Neurotrauma 2020; 37 (08) 1037-1051
  • 8 DeSana AJ, Estus S, Barrett TA, Saatman KE. Acute gastrointestinal permeability after traumatic brain injury in mice precedes a bloom in Akkermansia muciniphila supported by intestinal hypoxia. Sci Rep 2024; 14 (01) 2990
  • 9 Hanscom M, Loane DJ, Shea-Donohue T. Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury. J Clin Invest 2021; 131 (12) e143777
  • 10 Bansal V, Costantini T, Kroll L. et al. Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis. J Neurotrauma 2009; 26 (08) 1353-1359
  • 11 Iftikhar PM, Anwar A, Saleem S, Nasir S, Inayat A. Traumatic brain injury causing intestinal dysfunction: a review. J Clin Neurosci 2020; 79: 237-240
  • 12 Bouras M, Asehnoune K, Roquilly A. Immune modulation after traumatic brain injury. Front Med (Lausanne) 2022; 9: 995044
  • 13 Rusch JA, Layden BT, Dugas LR. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Front Endocrinol (Lausanne) 2023; 14: 1130689
  • 14 Faraji N, Payami B, Ebadpour N, Gorji A. Vagus nerve stimulation and gut microbiota interactions: a novel therapeutic avenue for neuropsychiatric disorders. Neurosci Biobehav Rev 2025; 169: 105990
  • 15 El Baassiri MG, Raouf Z, Badin S, Escobosa A, Sodhi CP, Nasr IW. Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies. J Neuroinflammation 2024; 21 (01) 124
  • 16 Celorrio M, Abellanas MA, Rhodes J. et al. Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis. Acta Neuropathol Commun 2021; 9 (01) 40
  • 17 Flinn H, Marshall A, Holcomb M. et al. Antibiotic treatment induces microbiome dysbiosis and reduction of neuroinflammation following traumatic brain injury in mice. Preprint Res Sq 2024;rs.3.rs-4475195
  • 18 Ritter K, Somnuke P, Hu L, Griemert EV, Schäfer MKE. Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models. BMC Neurosci 2024; 25 (01) 10
  • 19 Sgro M, Iacono G, Yamakawa GR, Kodila ZN, Marsland BJ, Mychasiuk R. Age matters: microbiome depletion prior to repeat mild traumatic brain injury differentially alters microbial composition and function in adolescent and adult rats. PLoS One 2022; 17 (11) e0278259
  • 20 O'Riordan KJ, Collins MK, Moloney GM. et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol 2022; 546: 111572
  • 21 Hodgkinson K, El Abbar F, Dobranowski P. et al. Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease. Clin Nutr 2023; 42 (02) 61-75
  • 22 Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 2020; 11: 25
  • 23 Ney LM, Wipplinger M, Grossmann M, Engert N, Wegner VD, Mosig AS. Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections. Open Biol 2023; 13 (03) 230014
  • 24 Moțățăianu A, Șerban G, Andone S. The role of short-chain fatty acids in microbiota-gut-brain cross-talk with a focus on amyotrophic lateral sclerosis: a systematic review. Int J Mol Sci 2023; 24 (20) 15094
  • 25 Duan H, Wang L, Huangfu M, Li H. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials. Biomed Pharmacother 2023; 165: 115276
  • 26 Celorrio M, Friess SH. Gut-brain axis in traumatic brain injury: impact on neuroinflammation. Neural Regen Res 2022; 17 (05) 1007-1008
  • 27 Taraskina A, Ignatyeva O, Lisovaya D. et al. Effects of traumatic brain injury on the gut microbiota composition and serum amino acid profile in rats. Cells 2022; 11 (09) 1409
  • 28 Wang S, Zhu K, Hou X, Hou L. The association of traumatic brain injury, gut microbiota and the corresponding metabolites in mice. Brain Res 2021; 1762: 147450
  • 29 Qian XH, Xie RY, Liu XL, Chen SD, Tang HD. Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer's disease. Aging Dis 2022; 13 (04) 1252-1266
  • 30 Huang Y, Wang YF, Miao J, Zheng RF, Li JY. Short-chain fatty acids: important components of the gut-brain axis against AD. Biomed Pharmacother 2024; 175: 116601
  • 31 Dixon CE, Kochanek PM, Yan HQ. et al. One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. J Neurotrauma 1999; 16 (02) 109-122
  • 32 Ramlackhansingh AF, Brooks DJ, Greenwood RJ. et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 2011; 70 (03) 374-383
  • 33 Opeyemi OM, Rogers MB, Firek BA. et al. Sustained dysbiosis and decreased fecal short-chain fatty acids after traumatic brain injury and impact on neurologic outcome. J Neurotrauma 2021; 38 (18) 2610-2621
  • 34 Yang W, Yuan Q, Li Z. et al. Translocation and dissemination of gut bacteria after severe traumatic brain injury. Microorganisms 2022; 10 (10) 2082
  • 35 Hanscom M, Loane DJ, Aubretch T. et al. Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits. J Neuroinflammation 2021; 18 (01) 24
  • 36 Guangliang H, Tao W, Danxin W, Lei L, Ye M. Critical knowledge gaps and future priorities regarding the intestinal barrier damage after traumatic brain injury. World Neurosurg 2024; 188: 136-149
  • 37 Treangen TJ, Wagner J, Burns MP, Villapol S. Traumatic brain injury in mice induces acute bacterial dysbiosis within the fecal microbiome. Front Immunol 2018; 9: 2757
  • 38 Ma Y, Liu T, Fu J. et al. Lactobacillus acidophilus exerts neuroprotective effects in mice with traumatic brain injury. J Nutr 2019; 149 (09) 1543-1552
  • 39 Simon DW, Rogers MB, Gao Y. et al. Depletion of gut microbiota is associated with improved neurologic outcome following traumatic brain injury. Brain Res 2020; 1747: 147056
  • 40 Davis IV BT, Chen Z, Islam MBAR, Timken ME, Procissi D, Schwulst SJ. Postinjury fecal microbiome transplant decreases lesion size and neuroinflammation in traumatic brain injury. Shock 2022; 58 (04) 287-294
  • 41 Frankot MA, O'Hearn CM, Blancke AM. et al. Acute gut microbiome changes after traumatic brain injury are associated with chronic deficits in decision-making and impulsivity in male rats. Behav Neurosci 2023; 137 (01) 15-28
  • 42 Medel-Matus JS, Simpson CA, Ahdoot AI. et al. Modification of post-traumatic epilepsy by fecal microbiota transfer. Epilepsy Behav 2022; 134: 108860
  • 43 Pechacek KM, Reck AM, Frankot MA, Vonder Haar C. Minocycline fails to treat chronic traumatic brain injury-induced impulsivity and attention deficits. Exp Neurol 2022; 348: 113924
  • 44 Zheng Z, Wang S, Wu C. et al. Gut microbiota dysbiosis after traumatic brain injury contributes to persistent microglial activation associated with upregulated Lyz2 and shifted tryptophan metabolic phenotype. Nutrients 2022; 14 (17) 3467
  • 45 Fagan MM, Welch CB, Scheulin KM. et al. Fecal microbial transplantation limits neural injury severity and functional deficits in a pediatric piglet traumatic brain injury model. Front Neurosci 2023; 17: 1249539
  • 46 Bao W, Sun Y, Lin Y, Yang X, Chen Z. An integrated analysis of gut microbiota and the brain transcriptome reveals host-gut microbiota interactions following traumatic brain injury. Brain Res 2023; 1799: 148149
  • 47 Ritter K, Vetter D, Wernersbach I, Schwanz T, Hummel R, Schäfer MKE. Pre-traumatic antibiotic-induced microbial depletion reduces neuroinflammation in acute murine traumatic brain injury. Neuropharmacology 2023; 237: 109648
  • 48 Gu N, Yan J, Tang W. et al. Prevotella copri transplantation promotes neurorehabilitation in a mouse model of traumatic brain injury. J Neuroinflammation 2024; 21 (01) 147
  • 49 Pasam T, Padhy HP, Dandekar MP. Lactobacillus helveticus improves controlled cortical impact injury-generated neurological aberrations by remodeling of gut-brain axis mediators. Neurochem Res 2024; 50 (01) 3
  • 50 Rewell SSJ, Shad A, Chen L. et al. A post-injury immune challenge with lipopolysaccharide following adult traumatic brain injury alters neuroinflammation and the gut microbiome acutely, but has little effect on chronic outcomes. Exp Neurol 2025; 386: 115150
  • 51 Nicholson SE, Watts LT, Burmeister DM. et al. Moderate traumatic brain injury alters the gastrointestinal microbiome in a time-dependent manner. Shock 2019; 52 (02) 240-248
  • 52 Howard BM, Kornblith LZ, Christie SA. et al. Characterizing the gut microbiome in trauma: significant changes in microbial diversity occur early after severe injury. Trauma Surg Acute Care Open 2017; 2 (01) e000108
  • 53 Pyles RB, Miller AL, Urban RJ. et al. The altered TBI fecal microbiome is stable and functionally distinct. Front Mol Neurosci 2024; 17: 1341808
  • 54 Seki D, Kirkegaard R, Osvatic J. et al. Gut microbiota genome features associated with brain injury in extremely premature infants. Gut Microbes 2024; 16 (01) 2410479
  • 55 Pristner M, Wasinger D, Seki D. et al. Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury. Cell Rep Med 2024; 5 (04) 101480
  • 56 Mahajan C, Khurana S, Kapoor I. et al. Characteristics of gut microbiome after traumatic brain injury. J Neurosurg Anesthesiol 2023; 35 (01) 86-90
  • 57 Brenner LA, Stamper CE, Hoisington AJ. et al. Microbial diversity and community structures among those with moderate to severe TBI: a United States-Veteran Microbiome Project Study. J Head Trauma Rehabil 2020; 35 (05) 332-341
  • 58 Cotoia A, Charitos IA, Corriero A, Tamburrano S, Cinnella G. The role of macronutrients and gut microbiota in neuroinflammation post-traumatic brain injury: a narrative review. Nutrients 2024; 16 (24) 4359
  • 59 Nwafor D, Goeckeritz J, Hasanpour Z, Davidson C, Lucke-Wold B. Nutritional support following traumatic brain injury: a comprehensive review. Explor Res Hypothesis Med 2023; 8 (03) 236-247